Jane Street Group, LLC Karyopharm Therapeutics Inc. Transaction History

Jane Street Group, LLC

  • $444 Billion
  • Q4 2024

A detailed history of Jane Street Group, LLC transactions in Karyopharm Therapeutics Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 748,306 shares of KPTI stock, worth $448,983. This represents 0.0% of its overall portfolio holdings.

Number of Shares
748,306
Previous 204,750 265.47%
Holding current value
$448,983
Previous $169,000 200.59%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$0.6 - $0.99 $326,133 - $538,120
543,556 Added 265.47%
748,306 $508,000
Q3 2024

Nov 14, 2024
SELL
$0.7 - $1.06 $941,658 - $1.43 Million
-1,345,226 Reduced 86.79%
204,750 $169,000
Q2 2024

Aug 14, 2024
BUY
$0.87 - $1.58 $1.2 Million - $2.18 Million
1,378,326 Added 802.99%
1,549,976 $1.35 Million
Q1 2024

May 15, 2024
SELL
$0.72 - $1.66 $74,743 - $172,324
-103,810 Reduced 37.69%
171,650 $259,000
Q4 2023

Feb 14, 2024
BUY
$0.68 - $1.31 $187,312 - $360,852
275,460 New
275,460 $236,000
Q2 2023

Aug 14, 2023
BUY
$1.79 - $4.59 $1.19 Million - $3.04 Million
662,363 New
662,363 $1.19 Million
Q4 2022

Feb 14, 2023
BUY
$2.48 - $5.93 $204,768 - $489,628
82,568 Added 559.1%
97,336 $330,000
Q3 2022

Nov 14, 2022
SELL
$4.08 - $5.82 $790,822 - $1.13 Million
-193,829 Reduced 92.92%
14,768 $81,000
Q3 2022

Nov 14, 2022
SELL
$4.08 - $5.82 $790,822 - $1.13 Million
-193,829 Reduced 92.92%
14,768 $81,000
Q2 2022

Aug 16, 2022
SELL
$4.15 - $8.37 $864,220 - $1.74 Million
-208,246 Reduced 49.96%
208,597 $941,000
Q1 2022

May 17, 2022
BUY
$5.91 - $14.38 $1.24 Million - $3.02 Million
209,700 Added 101.23%
416,843 $3.07 Million
Q4 2021

Feb 15, 2022
BUY
$5.21 - $8.61 $931,626 - $1.54 Million
178,815 Added 631.23%
207,143 $1.33 Million
Q3 2021

Nov 16, 2021
BUY
$4.45 - $10.63 $6,167 - $14,733
1,386 Added 5.14%
28,328 $165,000
Q2 2021

Aug 16, 2021
SELL
$8.11 - $11.11 $376,166 - $515,315
-46,383 Reduced 63.26%
26,942 $278,000
Q1 2021

May 18, 2021
BUY
$9.85 - $17.69 $23,314 - $41,872
2,367 Added 3.34%
73,325 $771,000
Q4 2020

Feb 17, 2021
SELL
$14.15 - $17.19 $162,258 - $197,117
-11,467 Reduced 13.91%
70,958 $1.1 Million
Q3 2020

Nov 17, 2020
SELL
$14.14 - $19.71 $354,829 - $494,602
-25,094 Reduced 23.34%
82,425 $1.2 Million
Q2 2020

Aug 17, 2020
BUY
$16.6 - $25.25 $1.54 Million - $2.34 Million
92,582 Added 619.82%
107,519 $2.04 Million
Q4 2019

Feb 14, 2020
SELL
$9.23 - $19.67 $59,865 - $127,579
-6,486 Reduced 30.28%
14,937 $286,000
Q3 2019

Nov 14, 2019
BUY
$5.66 - $11.85 $121,254 - $253,862
21,423 New
21,423 $206,000

Others Institutions Holding KPTI

# of Institutions
94
Shares Held
59.6M
Call Options Held
547K
Put Options Held
67K
View Full List

About Karyopharm Therapeutics Inc.

KPTI Quotes by TradingView
  • Ticker KPTI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 79,806,600
  • Market Cap $47.9M
  • Description
  • Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...
More about KPTI
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email